Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |